Accessibility Menu
 
Lotus Pharmaceuticals logo

Lotus Pharmaceuticals

(OTC) LTUS

Current Price$0.00
Market Cap$100,100
Since IPO (2006)-100%
5 Year-98%
1 Year-54%
1 Month-5%

Lotus Pharmaceuticals Financials at a Glance

Market Cap

$100,100

Revenue (TTM)

$0.00

Net Income (TTM)

$110.33K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.45 (Low)

Price

$0.00

Volume

10,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

LTUS News

No articles available.

LTUS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lotus Pharmaceuticals

Industry

Pharmaceuticals

Employees

13

CEO

Georgene Rivers

Headquarters

Nashville, TN 37207, US

LTUS Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

0%

Return on Assets

0%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.10K

Shares Outstanding

27.82M

Volume

10.00K

Short Interest

0.00%

Avg. Volume

10.31K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$29.03K

EBITDA

$29.03K

Operating Cash Flow

$19.13K

Capital Expenditure

$0.00

Free Cash Flow

$19.13K

Cash & ST Invst.

$1.90K

Total Debt

$116.68K

Lotus Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$100.10K

N/A

Market Cap/Employee

$429.61

N/A

Employees

233

N/A

Net Income

$6.40K

-11.7%

EBITDA

$6.40K

-11.7%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$123.01K

-15.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$123.43K

+15.6%

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

$3.85K

+41.5%

Operating Cash Flow

$3.85K

+41.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VNTAVentana Biotech, Inc.
$0.04+0.00%
AWWIAlpha Wastewater, Inc.
$0.00+0.00%
MNZOManzo Pharmaceuticals, Inc.
$0.00+0.00%
AWONA1 Group, Inc.
$0.00-25.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About LTUS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.